Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia

NCT07637162 · clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
300
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Axsome Therapeutics, Inc.